Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-25

Clinical Trial Update: Flushing in Social Anxiety Disorder on Seroquel [Phase 3]

View source ↗

Summary

A Phase 3 trial of quetiapine (Seroquel) for Social Anxiety Disorder has completed; the update centers on flushing as a reported side effect.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: START Clinic for Mood and Anxiety Disorders | Conditions: Social Anxiety Disorder | Phase 3 | Status: COMPLETED